日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern

在出现令人担忧的SARS-CoV-2变种病毒后,人群抗体免疫力发生了变化。

Bhiman, Jinal N; Madzorera, Vimbai Sharon; Mkhize, Qiniso; Scheepers, Cathrine; Hermanus, Tandile; Ayres, Frances; Makhado, Zanele; Moyo-Gwete, Thandeka; Crowther, Carol; Singh, Beverley; Fortuin, Mirriam; Marinda, Edmore; Jooste, Sean; Zuma, Khangelani; Zungu, Nompumelelo; Morris, Lynn; Puren, Adrian; Simbayi, Leickness; Moyo, Sizulu; Moore, Penny L

Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody

在HIV中和抗体的被动输注临床试验中,活性迅速丧失,但血清浓度未下降。

Mahomed, Sharana; Mkhize, Nonhlanhla N; Serebryannyy, Leonid A; Hermanus, Tandile; Kgagudi, Prudence; Kaldine, Haajira; Lambson, Bronwen; Narpala, Sandeep R; Basappa, Manjula; Castro, Mike; Lin, Bob C; Carlton, Kevin; Sands, Jason T; Gall, Jason G; Koup, Richard A; Morris, Lynn; Karim, Quarraisha Abdool; Moore, Penny L; Karim, Salim Abdool; Doria-Rose, Nicole

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

广谱中和抗体VRC01对抗体介导预防试验中HIV突破性病毒群体的影响

Williamson, Carolyn; Moodley, Chivonne; Magaret, Craig A; Giorgi, Elena E; Rolland, Morgane; Westfall, Dylan H; Yssel, Anna; Deng, Wenjie; Rossenkhan, Raabya; Mkhize, Nonhlanhla N; Chen, Lennie; Zhao, Hong; Bhattacharya, Tanmoy; Pankow, Alec; Murrell, Ben; York, Talita; Gwashu-Nyangiwe, Asanda; Ndabambi, Nonkululeko; Thebus, Ruwayhida; Cohen, Paula; Lambson, Bronwen; Kaldine, Haajira; Bhebhe, Sinethemba; Juraska, Michal; Bai, Hongjun; deCamp, Allan C; Ludwig, James; Molitor, Cindy; Beaume, Nicolas; Matten, David; Huang, Yunda; Zhang, Lily; Reeves, Daniel B; Mayer, Bryan; Karuna, Shelly T; Hural, John A; Morris, Lynn; Montefiori, David; Bumgarner, Roger E; Moore, Penny L; Edlefsen, Paul T; Edupuganti, Srilatha; Mgodi, Nyaradzo; McElrath, M Juliana; Cohen, Myron S; Corey, Lawrence; Gilbert, Peter B; Mullins, James I

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

VRC01 在抗体介导的预防试验中筛选出感染后出现的罕见 HIV 逃逸突变

Williamson, Carolyn; Curry, Lyle; Mkhize, Nonhlanhla N; Giorgi, Elena E; Magaret, Craig A; Lambson, Bronwen E; Hons, Sinethemba Bhebhe; Kaldine, Haajira; Moyo-Gwete, Thandeka; Rolland, Morgane; Rossenkhan, Raabya; Garcia, Nina Marie G; Moodley, Chivonne; Yssel, Anna; Huang, Yunda; Marsden, Alaine A; Reeves, Daniel B; Mayer, Bryan T; Bumgarner, Roger E; Beaume, Nicolas; Westfall, Dylan H; Juraska, Michal; DeCamp, Allan C; Murrell, Hugh; Bai, Hongjun; Deng, Wenjie; Pankow, Alec P; Bhattacharya, Tanmoy; York, Talita; Ndabambi, Nonkululeko; Chen, Lennie; Zhao, Hong; Gwashu-Nyangiri, Asanda; Thebus, Ruwayhida; Cohen, Paula; Murrell, Ben; Karuna, Shelly; Hural, John; Mgodi, Nyaradzo; Edupuganti, Srilatha; Morris, Lynn; Montefiori, David; McElrath, M Juliana; Cohen, Myron S; Corey, Lawrence; Edlefsen, Paul T; Gilbert, Peter B; Moore, Penny L; Mullins, James I

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

对ALVAC-HIV和二价C亚型gp120/MF59 HIV疫苗的性别差异免疫反应进行回顾性分析

Ackerley, Cassie G; Edupuganti, Srilatha; Yu, Chenchen; Roxby, Alison C; Seaton, Kelly E; Bekker, Linda-Gail; Allen, Mary; DeRosa, Stephen C; Yates, Nicole L; Heptinstall, Jack; Mkhize, Nonhlanhla N; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Furch, Briana D; Koutsoukos, Marguerite; Ferrari, Guido; Morris, Lynn; Montefiori, David C; McElrath, M Juliana; Tomaras, Georgia D; Laher, Fatima; Moodie, Zoe

Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women

CAP256V2LS(一种用于预防女性HIV感染的广谱中和抗体)按体重给药与固定剂量给药的群体药代动力学比较

Mahomed, Sharana; Beliveau, Martin; Heredia-Ortiz, Roberto; Osman, Farzana; Letsoalo, Marothi; Garrett, Nigel; Gengiah, Tanuja N; Archary, Derseree; Wang, Jennifer; Narpala, Sandeep; Castro, Mike; Serebryannyy, Leonid; Carlton, Kevin; Koup, Richard A; Moore, Penny L; Morris, Lynn; Abdool Karim, Quarraisha; Abdool Karim, Salim S

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

作者更正:在抗体介导预防试验中,高单克隆中和抗体滴度降低了突破性 HIV-1 病毒载量。

Reeves, Daniel B; Mayer, Bryan T; deCamp, Allan C; Huang, Yunda; Zhang, Bo; Carpp, Lindsay N; Magaret, Craig A; Juraska, Michal; Gilbert, Peter B; Montefiori, David C; Bar, Katharine J; Cardozo-Ojeda, E Fabian; Schiffer, Joshua T; Rossenkhan, Raabya; Edlefsen, Paul; Morris, Lynn; Mkhize, Nonhlanhla N; Williamson, Carolyn; Mullins, James I; Seaton, Kelly E; Tomaras, Georgia D; Andrew, Philip; Mgodi, Nyaradzo; Ledgerwood, Julie E; Cohen, Myron S; Corey, Lawrence; Naidoo, Logashvari; Orrell, Catherine; Goepfert, Paul A; Casapia, Martin; Sobieszczyk, Magdalena E; Karuna, Shelly T; Edupuganti, Srilatha

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

广谱中和抗体VRC01的预防效力取决于HIV-1包膜序列特征。

Juraska, Michal; Bai, Hongjun; deCamp, Allan C; Magaret, Craig A; Li, Li; Gillespie, Kevin; Carpp, Lindsay N; Giorgi, Elena E; Ludwig, James; Molitor, Cindy; Hudson, Aaron; Williamson, Brian D; Espy, Nicole; Simpkins, Brian; Rudnicki, Erika; Shao, Danica; Rossenkhan, Raabya; Edlefsen, Paul T; Westfall, Dylan H; Deng, Wenjie; Chen, Lennie; Zhao, Hong; Bhattacharya, Tanmoy; Pankow, Alec; Murrell, Ben; Yssel, Anna; Matten, David; York, Talita; Beaume, Nicolas; Gwashu-Nyangiwe, Asanda; Ndabambi, Nonkululeko; Thebus, Ruwayhida; Karuna, Shelly T; Morris, Lynn; Montefiori, David C; Hural, John A; Cohen, Myron S; Corey, Lawrence; Rolland, Morgane; Gilbert, Peter B; Williamson, Carolyn; Mullins, James I

Novel polymorphic and copy number diversity in the antibody IGH locus of South African individuals

南非个体抗体IGH基因座的新型多态性和拷贝数多样性

Marsden, Alaine A; Corcoran, Martin; Karlsson Hedestam, Gunilla; Garrett, Nigel; Karim, Salim S Abdool; Moore, Penny L; Kitchin, Dale; Morris, Lynn; Scheepers, Cathrine

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial

在接种C亚型ALVAC-HIV (vCP2438)疫苗初免后,再接种二价C亚型gp120/MF59疫苗加强针(HVTN 100)30个月后的安全性和免疫原性:一项1/2期随机双盲安慰剂对照试验

Naicker, Vimla; Laher, Fatima; Bekker, Linda-Gail; Seaton, Kelly E; Allen, Mary; De Rosa, Stephen; Yates, Nicole L; Mkhize, Nonhlanhla N; Saunders, Kevin; Heptinstall, Jack; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Yu, Chenchen; Modise, Tandile; Bekker, Valerie; Grunenberg, Nicole; Furch, Briana; Miner, Maurine D; Phogat, Sanjay; Diazgranados, Carlos A; Gurunathan, Sanjay; Koutsoukos, Marguerite; Van Der Meeren, Olivier; Roxby, Alison C; Ferrari, Guido; Morris, Lynn; Montefiori, David; McElrath, M Juliana; Tomaras, Georgia D; Moodie, Zoe